Systemic interferon type I and type II signatures in primary Sjogren's syndrome reveal differences in biological disease activity

Research output: Contribution to journalArticleAcademicpeer-review

107 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)921-930
Number of pages10
JournalRheumatology
Volume57
Issue number5
DOIs
Publication statusPublished - 2018

Research programs

  • EMC MM-02-72-02

Cite this